FDA Clears Cionic Neural Sleeve for Patients With Mobility Issues
The Cionic Neural Sleeve is the first product to combine movement analysis and augmentation into a wearable garment.
Diagnosis & Disease Information
Stratifying Patients With TIAs: Who Needs Hospitalization?
The Canadian TIA Score has the potential to effectively stratify the risk of future stroke or need for revascularization in the subsequent 7 days after transient ischemic event.
Novel Antithrombotic Fast Tracked for Noncardioembolic Ischemic Stroke
The Company is currently evaluating asundexian as monotherapy or in combination with antiplatelet therapy in the PACIFIC phase 2 clinical trial program.
Cannabis Use Tied to Delayed Cerebral Ischemia After Aneurysm Rupture
Researchers sought to investigate the effects of cannabis on delayed cerebral ischemia and other outcomes of patients with aneurysmal subarachnoid hemorrhage.
Atypical Posterior Stroke: Diagnosing Cause of Vertigo in Primary Care
A patient presenting with dizziness undergoes a thorough workup to identify a peripheral or central cause of vertigo.
USPSTF Draft Recommendation on Aspirin: What Approach Should Clinicians Take?
In an interview, Jeffrey S Berger, MD, shares his thoughts on updated USPSTF guidelines that address risk of major bleeding from aspirin use for primary prevention of CVD.
No Overall Benefit of Early Anticoagulant Therapy for Ischemic Stroke
In a Cochrane Review update, researchers sought to assess the effectiveness and safety of early anticoagulation for people with acute presumed or confirmed ischemic stroke.
Cardiovascular Disease Risk Increased in Young, Black US Adults
Researchers at AHA 2021 presented their findings from a study that compared CVD risk factors and in-hospital outcomes in young, Black US adults a decade apart.
Prognosis Discordant Common Between Families, Physicians in Severe Brain Injury
In a cross-sectional study, researchers sought to better understand prognosis discordance between physicians and families with patients with severe brain injury and the factors associated with it.
USPSTF: Starting Aspirin in Patients 60 or Older for Primary CVD Prevention Not Recommended
Starting aspirin in patients 60 years or older to prevent a first heart attack or stroke is not recommended.
- Loading...
Loading...
Next post in News
Loading... 
Loading...